$CTNM news
The latest CTNM stock news: headlines, filings, AI summaries and sentiment for $CTNM, updated around the clock.
- Contineum Therapeutics Reports Q3 GAAP EPS of -$0.49
- Contineum Therapeutics, Inc. - 10-Q Filing
- Contineum Therapeutics, Inc. - 8-K Filing
- Contineum Therapeutics Shares Drop After Failed Phase 2 Trial for Depression Drug
- Contineum Therapeutics, Inc. - 8-K Filing
- Johnson & Johnson's Top Investment Among Its Biotech Holdings
- Contineum Therapeutics, Inc. - 8-K Filing
- Contineum Therapeutics, Inc. - 8-K Filing
- Contineum Therapeutics, Inc. - 8-K Filing